SplitMay 19, 2026, 04:08 PM
Onconetix Announces 1-for-10 Reverse Stock Split Effective May 21
AI Summary
Onconetix, Inc. announced a 1-for-10 reverse stock split of its common stock, effective 12:01 a.m. Eastern Time on May 21, 2026. The Board of Directors fixed the ratio on May 8, 2026, following stockholder approval on April 30, 2026. This action is primarily intended to bring the company into compliance with Nasdaq's minimum bid price requirement. Trading on a split-adjusted basis will commence on May 21, 2026, under a new CUSIP number.
Key Highlights
- Onconetix's Board approved a 1-for-10 reverse stock split on May 8, 2026.
- The reverse stock split will be effective at 12:01 a.m. Eastern Time on May 21, 2026.
- Common stock will begin trading on a split-adjusted basis on Nasdaq from May 21, 2026, under new CUSIP 68237Q 401.
- The split is primarily intended to comply with Nasdaq's minimum bid price requirement of $1.00 per share.
- Outstanding shares will reduce from approximately 11.4 million to 1.14 million.
- No fractional shares will be issued; stockholders will receive cash for fractional entitlements.
- Proportional adjustments will be made to equity awards, convertible preferred stock, and warrants.
Price Impact
More from ONCO